GW405833 Inhibitor – Gw 405833

MBS5758593 is an inhibitor targeting GW405833. Also known as GW 405833. GW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective

Li A L, Carey L M, Mackie K, et al. The cannabinoid CB 2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB 1 mechanism that is independent of CB 2 receptors in mice[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 362(2):jpet.117.241901.
Li A L, Carey L M, Mackie K, et al. The cannabinoid CB 2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB 1 mechanism that is independent of CB 2 receptors in mice[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 362(2):jpet.117.241901.
Parlar A, Arslan S, Dogan, Muhammed, et al. The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress[J]. Experimental and Therapeutic Medicine, 2018.
Parlar A, Arslan S, Dogan, Muhammed, et al. The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress[J]. Experimental and Therapeutic Medicine, 2018.
Huang Z, Wang H, Wang J, et al. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca2+ oscillations in mouse pancreatic acinar cells[J]. Scientific Reports, 2016, 6(1):29757.
Huang Z, Wang H, Wang J, et al. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca2+ oscillations in mouse pancreatic acinar cells[J]. Scientific Reports, 2016, 6(1):29757.

Small volumes of GW405833, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.